Drugs & Targets Tecentriq receives accelerated approval as initial treatment for advanced bladder cancer April 21, 2017Vol.43 No.16
Drugs & Targets CTL019 receives breakthrough designation for treatment of diffuse large B-cell lymphoma April 21, 2017Vol.43 No.16
Drugs & Targets Health Canada approves Darzalex for treatment of multiple myeloma April 21, 2017Vol.43 No.16
Drugs & Targets FDA removes restrictions on use of erythropoiesis-stimulating agents April 14, 2017Vol.43 No.15
Drugs & Targets Human Vaccines Project, Vanderbilt and Illumina work to decode human immunome April 14, 2017Vol.43 No.15
Drugs & TargetsFree MD Anderson, Oncora Medical cooperate on precision radiation oncology April 07, 2017Vol.43 No.14
Drugs & TargetsFree Novartis drug combination Tafinlar + Mekinist receives EU approval for BRAF V600-positive advanced NSCLC April 07, 2017Vol.43 No.14
Drugs & TargetsFree FDA accepts for review the application of Ibrutinib for cGVHD after failure of systemic therapy April 07, 2017Vol.43 No.14
Drugs & TargetsFree Amgen seeks to expand XGEVA indications to multiple myeloma in the US, Europe April 07, 2017Vol.43 No.14
